Report Description

India betamethasone market is expected to grow at a steady rate during the forecast period. The India betamethasone market is driven by the widespread use of the drug for the treatment of a wide range of skin disorders including eczema, psoriasis, among others. Additionally, the increasing use of the medication in several rheumatic disorders such as rheumatoid arthritis, systemic lupus erythematosus, among others is further expected to fuel the market growth over the next few years. Besides, benefits such as easy availability and administration through different routes of administration such as oral, intravenous and topical are further expected to positively influence the market growth through FY2026. Also, the betamethasone cream and ointment are a part of the WHO’s list of essential medicines.

The India betamethasone market is segmented based on source, type, form, route of administration, distribution channel, application, end user, company and region. Based on distribution channel, the market can be split into online and offline. The offline channel is expected to dominate the market owing to the consumer preference for buying medicines from a pharmacy or drug store.

The major players operating in the India betamethasone market are Envee Drugs Pvt. Ltd., GlaxoSmithKline Pharmaceuticals Ltd, Dermocare Laboratories (Guj.) Pvt Ltd, Emson Medichem Pvt. Ltd, Cipla Limited, East West Pharma, Omega Remedies Pvt Ltd, Moraceae Pharmaceuticals Pvt. Ltd., Micro Labs Ltd, Pharmtak Ophtalmics Pvt. Ltd. and others. Major companies are developing advanced technologies, receiving approvals from regulatory bodies and launching new products in order to stay competitive in the market. Other competitive strategies include mergers & acquisitions and new product developments.

Years considered for this report:

Historical Years: FY2016-FY2019

Base Year: FY2020

Estimated Year: FY2021

Forecast Period: FY2022–FY2026

Objective of the Study:

  • To analyze and estimate the market size of India betamethasone market from FY2016 to FY2019.
  • To estimate and forecast the market size of India betamethasone market from FY2020 to FY2026 and growth rate until FY2026.
  • To classify and forecast India betamethasone market based on source, type, form, route of administration, distribution channel, application, end user, company and regional distribution.
  • To identify dominant region or segment in the India betamethasone market.
  • To identify drivers and challenges for India betamethasone market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in India betamethasone market.
  • To identify and analyze the profile of leading players operating in India betamethasone market.
  • To identify key sustainable strategies adopted by market players in India betamethasone market.

Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of India betamethasone market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Betamethasone manufacturers/ suppliers/ distributors
  • Market research and consulting firms
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to betamethasone

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, India betamethasone market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • India Betamethasone Market, By Source:
    • In-House
    • Contract Manufacturing Organizations
  • India Betamethasone Market, By Type:
    • Betamethasone Dipropionate
    • Betamethasone Sodium Phosphate
    • Betamethasone Valerate
  • India Betamethasone Market, By Form:
    • Cream
    • Ointment & Lotion
    • Injection-Solution
    • Spray & Foam
    • Others
  • India Betamethasone Market, By Route of Administration:
    • Parenteral
    • Ophthalmic
    • Topical
    • Infiltration
    • Intra-articular/Intralesional/Intramuscular
  • India Betamethasone Market, By Distribution Channel:
    • Online
    • Offline
  • India Betamethasone Market, By Application:
    • Eczema
    • Psoriasis
    • Dermatitis
    • Others
  • India Betamethasone Market, By End User:
    • Hospitals & Clinics
    • Homecare
  • India Betamethasone Market, By Region:
    • North
    • South
    • East
    • West

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in India betamethasone market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
India Betamethasone market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]  

Table of content

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Betamethasone Market

4.    Executive Summary

5.    Manufacturing Betamethasone

5.1.  Raw Material

5.2.  Machinery

5.3.  Manufacturing Methods

5.4.  Contact Details of Machinery & Raw Material Suppliers

6.    Pharmacodynamic Overview of Betamethasone

6.1.  Mechanism of Action

6.2.  Absorption

6.3.  Volume of Distribution

6.4.  Protein Binding

6.5.  Metabolism

6.6.  Route of Elimination

6.7.  Half-Life

6.8.  Clearance

6.9.  Toxicity

7.    India Betamethasone Market Outlook

7.1.  Market Size & Forecast

7.1.1.     By Value & Volume

7.2.  Market Share & Forecast

7.2.1.     By Source (In-house v/s Contract Manufacturing Organizations)

7.2.2.     By Type (Betamethasone Dipropionate, Betamethasone Sodium Phosphate, Betamethasone Valerate)

7.2.3.     By Form (Cream, Ointment & Lotion, Injection-Solution, Spray & Foam, Others)

7.2.4.     By Route of Administration (Parenteral, Ophthalmic, Topical, Infiltration, Intra-articular/Intralesional/Intramuscular)

7.2.5.     By Distribution Channel (Online v/s Offline)

7.2.6.     By Application (Eczema, Psoriasis, Dermatitis, Others)

7.2.7.     By End User (Hospitals & Clinics v/s Homecare)

7.2.8.     By Region (North, East, South, West)

7.2.9.     By Company

7.3.  Product Market Map

8.    Market Dynamics

8.1.  Drivers/Opportunities

8.2.  Challenges/Restraints

9.    Market Trends & Developments

10.  Policy & Regulatory Landscape

10.1.              Custom Duty & Taxes

10.2.              Government Subsidy & Benefits

10.3.              Relevant Policies & Regulations (GMP, USFDA, WHO Certifications)

11.  Import & Export Analysis

12.  Pricing Analysis

13.  India Economic Profile

14.  Competitive Landscape

14.1.              Company Profiles

14.1.1.  Envee Drugs Pvt. Ltd.      Company Brief      Production Plants & Capacity      Financials (If Available)      Captive Consumption Vs Merchant Sale      Current & Future Plans

14.1.2.  GlaxoSmithKline Pharmaceuticals Ltd

14.1.3.  Dermocare Laboratories (Guj.) Pvt Ltd

14.1.4.  Emson Medichem Pvt. Ltd

14.1.5.  Cipla Limited

14.1.6.  East West Pharma

14.1.7.  Omega Remedies Pvt Ltd

14.1.8.  Moraceae Pharmaceuticals Pvt. Ltd.

14.1.9.  Micro Labs Ltd

14.1.10.                Pharmtak Ophtalmics Pvt. Ltd.

15.  Strategic Recommendations

16.  About us & Disclaimer        

Figures and Tables

Frequently asked questions